Industry: Healthcare | Pharmaceutical | Biotech

Using Riverbed®, GSK experienced a 50 percent decrease in overall network traffic.

In Brief

  • Improved network performance to accommodate new messaging platform
  • Easy-to-deploy technology allowed for fast implementation in 40 countries
  • Gave company visibility into network performance enterprise-wide

Headquartered in the United Kingdom, GlaxoSmithKline (GSK) is Europe’s largest pharmaceutical manufacturer and the third largest company of its kind in the world. When GSK decided to move its internally hosted messaging infrastructure to an externally hosted Microsoft platform, improving the performance of its network and collaboration environment was a core requirement.

GSK turned to Riverbed to meet this critical demand. With Riverbed, GSK has not only been able to reduce traffic, but has also gained complete visibility into network performance across the enterprise.

Tell Us Your Story
$mainImageBigHTML ×

Riverbed, at more than $1 billion in annual revenue, is the leader in application performance infrastructure, delivering the most complete platform for the hybrid enterprise to ensure applications perform as expected, data is always available when needed, and performance issues can be proactively detected and resolved before impacting business performance. Riverbed enables hybrid enterprises to transform application performance into a competitive advantage by maximizing employee productivity and leveraging IT to create new forms of operational agility. Riverbed’s 27,000+ customers include 97% of the Fortune 100 and 98% of the Forbes Global 100.

We need your email to add to briefcase!


Update your Profile!